ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,806Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 1107

$1.12M Total Retail Price of All Prescriptions

Rank: 70 out of 1107

722 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 722 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 722 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 17,330 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 761 609 1 4
FUROSEMIDE 693 612 2 7
HYDROCODONE-ACETAMINOPHEN 683 425 S3 3 1
LEVOTHYROXINE SODIUM 664 542 4 3
WARFARIN SODIUM 410 370 5 15
GABAPENTIN 404 267 6 9
POTASSIUM CHLORIDE 387 354 7 14
AMLODIPINE BESYLATE 384 355 8 6
METOPROLOL SUCCINATE 377 305 9 16
LISINOPRIL 376 277 10 2
SIMVASTATIN 366 337 11 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 364 268 12 24
LACTULOSE 345 327 13 89
CITALOPRAM HBR 311 284 14 17
METFORMIN HCL 307 224 15 8
DONEPEZIL HCL 300 300 16 32
METOPROLOL TARTRATE 290 222 17 10
SERTRALINE HCL 273 238 18 20
DICLOFENAC SODIUM 272 220 19 74
ATENOLOL 232 181 20 19
ZOLPIDEM TARTRATE 228 155 21 22
CARVEDILOL 216 193 22 27
DIGOXIN 198 176 23 52
NEXIUM 190 125 24 18
POLYETHYLENE GLYCOL 3350 189 152 25 46
CEPHALEXIN 182 136 26 81
DOXAZOSIN MESYLATE 173 140 27 92
LOSARTAN-HYDROCHLOROTHIAZIDE 161 131 28 66
ALBUTEROL SULFATE 161 152 28 144
ALLOPURINOL 159 150 30 36
TRAZODONE HCL 157 136 31 33
PRAVASTATIN SODIUM 151 91 32 12
FLUOXETINE HCL 140 49 33 47
LANTUS 137 87 34 49
NYSTATIN 135 115 35 110
ATORVASTATIN CALCIUM 133 119 36 13
TRAMADOL HCL 133 97 36 26
PREDNISONE 129 91 38 40
RISPERIDONE 128 116 39 79
TRIAMTERENE-HCTZ 127 100 40 62
QUETIAPINE FUMARATE 122 100 41 94
TAMSULOSIN HCL 121 121 42 30
IPRATROPIUM-ALBUTEROL 120 118 43 154
ADVAIR DISKUS 120 97 43 54
RANITIDINE HCL 120 94 43 21
CYMBALTA 119 69 46 50
ALENDRONATE SODIUM 119 102 46 41
BENZTROPINE MESYLATE 118 108 R 48 174
NAMENDA 112 112 49 42
KLOR-CON 10 112 92 49 143
LOSARTAN POTASSIUM 109 102 51 29
ESCITALOPRAM OXALATE 104 88 52 82
BUSPIRONE HCL 104 93 52 107
RAMIPRIL 101 101 54 84
DIVALPROEX SODIUM 100 93 55 96
CIPROFLOXACIN HCL 99 72 56 59
MELOXICAM 95 64 57 25
CLOPIDOGREL 95 87 57 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 80 59 88
FLUTICASONE PROPIONATE 91 75 60 38
MIRTAZAPINE 91 77 60 61
LORAZEPAM 90 72 62 155
BACLOFEN 87 26 63 133
LEVOFLOXACIN 85 72 64 71
AMITRIPTYLINE HCL 84 61 R 65 48
SINGULAIR 79 68 66 65
PLAVIX 78 57 67 39
PROMETHAZINE HCL 77 56 R 68 44
CLONIDINE HCL 77 71 68 53
ROPINIROLE HCL 75 75 70 69
COMBIVENT 75 60 70 112
METFORMIN HCL ER 75 52 70 58
VENTOLIN HFA 74 30 73 97
DOXYCYCLINE HYCLATE 72 57 74 128
LANSOPRAZOLE 69 67 75 102
KLOR-CON M10 66 51 76 159
EXELON 66 66 76 103
OXYCODONE-ACETAMINOPHEN 65 55 S2 78 104
IBUPROFEN 65 43 78 63
CYCLOBENZAPRINE HCL 64 48 R 80 56
AMOX TR-POTASSIUM CLAVULANATE 63 44 81 131
SPIRIVA 63 60 81 57
LYRICA 63 19 81 83
HYDROCHLOROTHIAZIDE 63 49 81 11
PAROXETINE HCL 62 62 85 45
OXYCODONE HCL-ACETAMINOPHEN 62 17 S2 85 93
OXYBUTYNIN CHLORIDE ER 62 62 85 179
ATENOLOL-CHLORTHALIDONE 62 45 85 189
BUDESONIDE 62 62 85 291
PROAIR HFA 61 29 90 37
GLYBURIDE-METFORMIN HCL 61 55 R 90 165
SPIRONOLACTONE 61 50 90 72
BENAZEPRIL HCL 60 55 93 86
TRIAMCINOLONE ACETONIDE 60 34 93 137
PHENYTOIN SODIUM EXTENDED 59 29 95 147
DILTIAZEM ER 58 46 96 139
OXYCONTIN 58 30 S2 96 167
DIOVAN 58 54 96 51
MONTELUKAST SODIUM 57 45 99 118
CARBIDOPA-LEVODOPA 57 57 99 122
NOVOLOG 56 45 101 127
GEMFIBROZIL 55 28 102 107
SYNTHROID 54 54 103 70
METOLAZONE 54 52 103 217
CARBAMAZEPINE 54 36 103 215
FINASTERIDE 53 53 106 130
BYSTOLIC 53 53 106 138
TRAVATAN Z 52 52 108 311
LOVASTATIN 52 27 108 55
GLIPIZIDE ER 51 50 110 115
ACETAMINOPHEN-CODEINE 50 49 S3 111 120
VERAPAMIL ER 50 50 111 113
VESICARE 50 50 111 228
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 23, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.